FDA extends review period for Incyte's sNDA for ruxolitinib cream
The US FDA has extended the review period for Incyte’s supplemental New Drug Application (sNDA) for ruxolitinib cream (Opzelura) to treat vitiligo.
Page 13 - Steven Stein News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Steven Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Steven Stein Today - Breaking & Trending Today
Disqus and Akismet Sign a Multi-year Partnership to Fight Spam on the Web
/PRNewswire/ -- Akismet, the popular anti-spam product developed by Automattic, is announcing a multi-year partnership with Disqus, a comment hosting service...
Source: prnewswire.com
Obsidian Partners with SafeLease to Provide Tenant Protection Program
/PRNewswire/ -- Obsidian, an A.M. Best rated "AA-" hybrid fronting program carrier, has teamed up with SafeLease Insurance Services to provide a novel tenant...
Source: prnewswire.com
Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021
Posted on 244 Incyte (Nasdaq:INCY) today announced that multiple abstracts from across its oncology portfolio will be presented during Week 1 of the upcoming American Association for Cancer Research (AACR) Annual Meeting 2021, held virtually from April 10-15, 2021. “At AACR 2021, we look forward to sharing clinical and pre-clinical data from INCB106385, our novel A2A/A2B adenosine receptor antagonist, and INCA00186, our novel CD73 monoclonal antibody—both of which highlight our ongoing efforts targeting the adenosine pathway. P...
Source: financialbuzz.com
Advocacy groups and companies try to influence vaccine decisions
Updated: 12:36 PM CST Jan 27, 2021 About 60 different groups and companies wrote letters to influence COVID-19 vaccine decisions in Iowa.KCRG reports states can make their own decisions on who is eligible for vaccinations, even though the Centers for Disease Control and Prevention makes its own recommendations on who should be prioritized for the limited doses of vaccine available.In Iowa, the Infectious Disease Advisory Council creates recommendations to the Iowa Department of Public Health director and medical director in developing COVID-19 vaccine distribution and therapy guidan...
Source: kcci.com